Medtronic announced multi-year renewal and large expansion of its strategic alliance with GE HealthCare in patient care solutions.

The duo has collaborated on healthcare technology for over three decades. The agreement expansion aims to speed clinical and technology innovation and let healthcare providers deliver smart, safe, and efficient care in hospitals.

The long alliance is also targeting future innovations, with a plan to adopt next-gen Medtronic tech in GE HealthCare’s Patient Care Solutions platforms. This includes growth into wireless wearable solutions and anesthesia airway visualization.

“Our expanded alliance with GE HealthCare reflects our commitment to empowering healthcare professionals with world-class technology to personalize patient care, anytime, anywhere,” said Kate Benedict, president of Medtronic’s Acute Care & Monitoring business. “Expanding access to our combined technologies and commercial solutions allows hospitals to streamline their operations, reduce inefficiencies, and ultimately empower clinicians to focus on what matters most: their patients.”

Medtronic’s Nellcor pulse oximetry, Microstream capnography, INVOS regional oximetry, and BIS brain monitoring will be combined with GE HealthCare’s FlexAcuity platforms and CARESCAPE Canvas and Carevance monitors. Together, the integrations support patient-adaptable monitoring and efficient patient care.

The alliance also features expanded commercial initiatives between Medtronic Acute & Monitoring and GE HealthCare Patient Care Solutions. Together, the partnership seeks integrated enterprise solutions to enhance outcomes and drive innovation.

“We are excited to continue to collaborate with GE HealthCare to bring our newest innovations in wireless wearable monitoring and seamless streaming video laryngoscopy from Medtronic to GE HealthCare’s anesthesia and monitoring platforms,” said Jason Case, VP of R&D for Medtronic Acute Care & Monitoring. “Expanding our deep, long-standing strategic alliance with GE HealthCare helps ensure timely access to the latest innovative technologies for both clinicians and their patients.”